Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 08-Nov-24
Select bar for recommendation details.
Recommendations | 08-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Maravai Lifesciences Holdings Inc have a median target of 9.50, with a high estimate of 13.20 and a low estimate of 7.00. The median estimate represents a 66.67% increase from the last price of 5.70.
High | 131.6% | 13.20 |
Med | 66.7% | 9.50 |
Low | 22.8% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | -39.35% |
More ▼
Revenue history & estimates in USD
Average growth rate | +0.16% |
Average growth rate | +41.51% |
More ▼